Goldman Sachs’s CASI Pharmaceuticals CASI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,447
Closed -$20K 6474
2022
Q1
$20K Sell
2,447
-2,593
-51% -$20.4K ﹤0.01% 6411
2021
Q4
$40K Sell
5,040
-14,959
-75% -$149K ﹤0.01% 6296
2021
Q3
$238K Buy
19,999
+4,881
+32% +$66K ﹤0.01% 5635
2021
Q2
$234K Buy
15,118
+8,913
+144% +$150K ﹤0.01% 5666
2021
Q1
$149K Buy
6,205
+3,247
+110% +$91.2K ﹤0.01% 5744
2020
Q4
$87K Sell
2,958
-14,705
-83% -$320K ﹤0.01% 5312
2020
Q3
$271K Buy
17,663
+16,501
+1,420% +$311K ﹤0.01% 4785
2020
Q2
$29K Sell
1,162
-1,749
-60% -$38K ﹤0.01% 5108
2020
Q1
$59K Sell
2,911
-1,879
-39% -$44.8K ﹤0.01% 5024
2019
Q4
$148K Buy
4,790
+1,300
+37% +$42.2K ﹤0.01% 4980
2019
Q3
$117K Buy
3,490
+1,671
+92% +$53.6K ﹤0.01% 4940
2019
Q2
$58K Sell
1,819
-1,524
-46% -$48.7K ﹤0.01% 5006
2019
Q1
$96K Buy
3,343
+428
+15% +$14.9K ﹤0.01% 4932
2018
Q4
$118K Buy
2,915
+63
+2% +$2.39K ﹤0.01% 4969
2018
Q3
$133K Buy
+2,852
New +$199K ﹤0.01% 5044
2018
Q2
Sell
-17,806
Closed -$743K 5675
2018
Q1
$743K Buy
17,806
+15,920
+844% +$594K ﹤0.01% 4237
2017
Q4
$61K Buy
+1,886
New +$51.2K ﹤0.01% 5890
2016
Q4
Sell
-2,475
Closed -$27K 6903
2016
Q3
$27K Sell
2,475
-543
-18% -$5.96K ﹤0.01% 6668
2016
Q2
$35K Buy
+3,018
New +$38.1K ﹤0.01% 6540

Other funds holding CASI